-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Sangamo Therapeutics, Inc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2011 to Q1 2025.
- Sangamo Therapeutics, Inc Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$26.1M, a 46.3% increase year-over-year.
- Sangamo Therapeutics, Inc annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$67.1M, a 70.1% increase from 2023.
- Sangamo Therapeutics, Inc annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$225M, a 0.54% decline from 2022.
- Sangamo Therapeutics, Inc annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$224M, a 4.13% increase from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)